{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,4]],"date-time":"2026-04-04T05:10:17Z","timestamp":1775279417636,"version":"3.50.1"},"reference-count":27,"publisher":"Japanese Society for Lymphoreticular Tissue Research","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JCEH","J Clin Exp Hematopathol"],"published-print":{"date-parts":[[2026]]},"DOI":"10.3960\/jslrt.25075","type":"journal-article","created":{"date-parts":[[2026,1,19]],"date-time":"2026-01-19T22:06:54Z","timestamp":1768860414000},"page":"85-90","source":"Crossref","is-referenced-by-count":0,"title":["Primary gastric EBV-positive cytotoxic-molecule\u2013negative T-cell                    lymphoma with &lt;i&gt;TET2&lt;\/i&gt; multihit mutations: a case                    report"],"prefix":"10.3960","volume":"66","author":[{"given":"Masako","family":"Kurashige","sequence":"first","affiliation":[{"name":"Department of Pathology, Graduate School of Medicine, The                            University of Osaka, Suita, Osaka, Japan,"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akihisa","family":"Hino","sequence":"additional","affiliation":[{"name":"Department of Hematology and Oncology, Graduate School of                            Medicine, The University of Osaka, Suita, Osaka, Japan,"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Koki","family":"Muto","sequence":"additional","affiliation":[{"name":"Department of Pathology, Graduate School of Medicine, The                            University of Osaka, Suita, Osaka, Japan,"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Keisuke","family":"Nagahama","sequence":"additional","affiliation":[{"name":"Department of Hematology and Oncology, Graduate School of                            Medicine, The University of Osaka, Suita, Osaka, Japan,"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takehiro","family":"Yamamoto","sequence":"additional","affiliation":[{"name":"Department of Pathology, Graduate School of Medicine, The                            University of Osaka, Suita, Osaka, Japan,"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Keiichi","family":"Nakata","sequence":"additional","affiliation":[{"name":"Department of Hematology, Suita Municipal Hospital, Suita,                            Osaka, Japan,"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michiko","family":"Ichii","sequence":"additional","affiliation":[{"name":"Department of Hematology and Oncology, Graduate School of                            Medicine, The University of Osaka, Suita, Osaka, Japan,"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kentaro","family":"Fukushima","sequence":"additional","affiliation":[{"name":"Department of Hematology and Oncology, Graduate School of                            Medicine, The University of Osaka, Suita, Osaka, Japan,"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kennosuke","family":"Karube","sequence":"additional","affiliation":[{"name":"Department of Pathology and Laboratory Medicine, Graduate                            School of Medicine, Nagoya University, Nagoya, Japan,"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasuhito","family":"Nannya","sequence":"additional","affiliation":[{"name":"Division of Hematopoietic Disease Control, The Institute of                            Medical Science, The University of Tokyo, Tokyo, Japan,"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naoki","family":"Hosen","sequence":"additional","affiliation":[{"name":"Department of Hematology and Oncology, Graduate School of                            Medicine, The University of Osaka, Suita, Osaka, Japan,"},{"name":"Laboratory of Cellular Immunotherapy, World Premier                            International Immunology Frontier Research Center, The University of                            Osaka, Suita, Osaka, Japan,"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Seishi","family":"Ogawa","sequence":"additional","affiliation":[{"name":"Department of Pathology and Tumor Biology, Kyoto University,                            Kyoto, Japan,"},{"name":"Institute for the Advanced Study of Human Biology (WPI-ASHBi),                            Kyoto University, Kyoto, Japan,"},{"name":"Department of Innovative Medicine, Faculty of Medicine, Kindai University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eiichi","family":"Morii","sequence":"additional","affiliation":[{"name":"Department of Pathology, Graduate School of Medicine, The                            University of Osaka, Suita, Osaka, Japan,"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"2349","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1 Kataoka                            K,                                Shiraishi                            Y,                                Takeda                            Y                    <i>et al.<\/i> Aberrant PD-L1 expression through 3&apos;-UTR disruption in                    multiple cancers. Nature. 2016; 534: 402-406.","DOI":"10.1038\/nature18294"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2 Kataoka                            K,                                Miyoshi                            H,                                Sakata                            S                    <i>et al.<\/i> Frequent structural variations involving programmed                    death ligands in Epstein-Barr virus-associated lymphomas. Leukemia. 2019; 33:                    1687-1699.","DOI":"10.1038\/s41375-019-0380-5"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3 Kimura                            H,                                Okuno                            Y,                                Sato                            Y,                                Watanabe                            T,                                Murata                            T. Deletion of                    Viral microRNAs in the Oncogenesis of Epstein-Barr Virus-Associated Lymphoma.                    Front Microbiol. 2021; 12: 667968.","DOI":"10.3389\/fmicb.2021.667968"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4 Khine                            HT,                                Sato                            Y,                                Hamada                            M                    <i>et al.<\/i> Association of Epstein-Barr virus genomic alterations                    with human pathologies. Blood. 2025; 146: 1533-1545.","DOI":"10.1182\/blood.2024028055"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5 Bednarska                            K,                                Chowdhury                            R,                                Tobin                            JWD                    <i>et al.<\/i> Epstein-Barr virus-associated lymphomas decoded. Br J                    Haematol. 2024; 204: 415-433.","DOI":"10.1111\/bjh.19255"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6 Hue                            SS,                                Oon                            ML,                                Wang                            S,                                Tan                            SY,                                Ng                            SB. Epstein-Barr                    virus-associated T- and NK-cell lymphoproliferative diseases: an update and                    diagnostic approach. Pathology. 2020; 52: 111-127.","DOI":"10.1016\/j.pathol.2019.09.011"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7 Kimura                            H, de                                Leval                            L,                                Cai                            Q,                                Kim                            WS.                    EBV-associated NK and T-cell lymphoid neoplasms. Curr Opin Oncol. 2022; 34:                    422-431.","DOI":"10.1097\/CCO.0000000000000889"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8 Quintanilla-Martinez                            L,                                Swerdlow                            SH,                                Tousseyn                            T                    <i>et al.<\/i> New concepts in EBV-associated B, T, and NK cell                    lymphoproliferative disorders. Virchows Arch. 2023; 482:                    227-244.","DOI":"10.1007\/s00428-022-03414-4"},{"key":"9","unstructured":"9 WHO Classification of Tumours Editorial                    Board: Haematolymphoid tumours, World Health Organization International Agency                    for Research on Cancer. 2024."},{"key":"10","doi-asserted-by":"crossref","unstructured":"10 Kim                            SJ,                                Yoon                            DH,                                Jaccard                            A                    <i>et al.<\/i> A prognostic index for natural killer cell lymphoma                    after non-anthracycline-based treatment: a multicentre, retrospective analysis.                    Lancet Oncol. 2016; 17: 389-400.","DOI":"10.1016\/S1470-2045(15)00533-1"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11 Suzuki                            R,                                Suzumiya                            J,                                Yamaguchi                            M                    <i>et al.<\/i> Prognostic factors for mature natural killer (NK) cell                    neoplasms: aggressive NK cell leukemia and extranodal NK cell lymphoma, nasal                    type. Ann Oncol. 2010; 21: 1032-1040.","DOI":"10.1093\/annonc\/mdp418"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12 Takata                            K,                                Hong                            ME,                                Sitthinamsuwan                            P                    <i>et al.<\/i> Primary cutaneous NK\/T-cell lymphoma, nasal type and                    CD56-positive peripheral T-cell lymphoma: a cellular lineage and                    clinicopathologic study of 60 patients from Asia. Am J Surg Pathol. 2015; 39:                    1-12.","DOI":"10.1097\/PAS.0000000000000312"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13 Hong                            M,                                Lee                            T, Young                                Kang                            S                    <i>et al.<\/i> Nasal-type NK\/T-cell lymphomas are more frequently T                    rather than NK lineage based on T-cell receptor gene, RNA, and protein studies:                    lineage does not predict clinical behavior. Mod Pathol. 2016; 29:                    430-443.","DOI":"10.1038\/modpathol.2016.47"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14 Koo                            GC,                                Tan                            SY,                                Tang                            T                    <i>et al.<\/i> Janus kinase 3-activating mutations identified in                    natural killer\/T-cell lymphoma. Cancer Discov. 2012; 2:                    591-597.","DOI":"10.1158\/2159-8290.CD-12-0028"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15 Bouchekioua                            A,                                Scourzic                            L, de                                Wever                            O                    <i>et al.<\/i> JAK3 deregulation by activating mutations confers                    invasive growth advantage in extranodal nasal-type natural killer cell lymphoma.                    Leukemia. 2014; 28: 338-348.","DOI":"10.1038\/leu.2013.157"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16 Kucuk                            C,                                Jiang                            B,                                Hu                            X                    <i>et al.<\/i> Activating mutations of STAT5B and STAT3 in lymphomas                    derived from gammadelta-T or NK cells. Nat Commun. 2015; 6:                    6025.","DOI":"10.1038\/ncomms7025"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17 Lee                            S,                                Park                            HY,                                Kang                            SY                    <i>et al.<\/i> Genetic alterations of JAK\/STAT cascade and histone                    modification in extranodal NK\/T-cell lymphoma nasal type. Oncotarget. 2015; 6:                    17764-17776.","DOI":"10.18632\/oncotarget.3776"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18 Song                            TL,                                Nairismagi                            ML,                                Laurensia                            Y                    <i>et al.<\/i> Oncogenic activation of the STAT3 pathway drives PD-L1                    expression in natural killer\/T-cell lymphoma. Blood. 2018; 132:                    1146-1158.","DOI":"10.1182\/blood-2018-01-829424"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19 Jo                            JC,                                Kim                            M,                                Choi                            Y                    <i>et al.<\/i> Expression of programmed cell death 1 and programmed                    cell death ligand 1 in extranodal NK\/T-cell lymphoma, nasal type. Ann Hematol.                    2017; 96: 25-31.","DOI":"10.1007\/s00277-016-2818-4"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20 Ito                            Y,                                Marouf                            A,                                Kogure                            Y                    <i>et al.<\/i> Comprehensive Genetic Profiling Reveals Frequent                    Alterations of Driver Genes on the X Chromosome in Extranodal NK\/T-cell                    Lymphoma. Cancer Res. 2024; 84: 2181-2201.","DOI":"10.1158\/0008-5472.CAN-24-0132"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21 Couronne                            L,                                Bastard                            C,                                Bernard                            OA. TET2 and                    DNMT3A mutations in human T-cell lymphoma. N Engl J Med. 2012; 366:                    95-96.","DOI":"10.1056\/NEJMc1111708"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22 Sakata-Yanagimoto                            M,                                Enami                            T,                                Yoshida                            K                    <i>et al.<\/i> Somatic RHOA mutation in angioimmunoblastic T cell                    lymphoma. Nat Genet. 2014; 46: 171-175.","DOI":"10.1038\/ng.2872"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23 Kato                            S,                                Hamada                            M,                                Okamoto                            A                    <i>et al.<\/i> EBV+ nodal T\/NK-cell lymphoma associated with clonal                    hematopoiesis and structural variations of the viral genome. Blood Adv. 2024; 8:                    2138-2147.","DOI":"10.1182\/bloodadvances.2023012019"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24 Wai                            CMM,                                Chen                            S,                                Phyu                            T                    <i>et al.<\/i> Immune pathway upregulation and lower genomic                    instability distinguish EBV-positive nodal T\/NK-cell lymphoma from ENKTL and                    PTCL-NOS. Haematologica. 2022; 107: 1864-1879.","DOI":"10.3324\/haematol.2021.280003"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25 Zhang                            Z,                                Wang                            W,                                Li                            Y                    <i>et al.<\/i> A nodal EBV-positive T cell lymphoma with a T follicular                    helper cell phenotype. Histopathology. 2023; 83: 137-142.","DOI":"10.1111\/his.14919"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26 Kato                            S,                                Asano                            N,                                Miyata-Takata                            T                    <i>et al.<\/i> T-cell receptor (TCR) phenotype of nodal Epstein-Barr                    virus (EBV)-positive cytotoxic T-cell lymphoma (CTL): a clinicopathologic study                    of 39 cases. Am J Surg Pathol. 2015; 39: 462-471.","DOI":"10.1097\/PAS.0000000000000323"},{"key":"27","doi-asserted-by":"crossref","unstructured":"27 Ng                            SB,                                Chung                            TH,                                Kato                            S                    <i>et al.<\/i> Epstein-Barr virus-associated primary nodal T\/NK-cell                    lymphoma shows a distinct molecular signature and copy number changes.                    Haematologica. 2018; 103: 278-287.","DOI":"10.3324\/haematol.2017.180430"}],"container-title":["Journal of Clinical and Experimental Hematopathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jslrt\/66\/1\/66_25075\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,4]],"date-time":"2026-04-04T04:31:11Z","timestamp":1775277071000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jslrt\/66\/1\/66_25075\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026]]},"references-count":27,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.3960\/jslrt.25075","relation":{},"ISSN":["1346-4280","1880-9952"],"issn-type":[{"value":"1346-4280","type":"print"},{"value":"1880-9952","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026]]},"article-number":"25075"}}